MTAP, the Myozyme® (alglucosidase alfa) Temporary Access Program, is a clinical program to provide access to Myozyme produced by a

Genzyme would like to take this opportunity to provide a brief update to the Pompe patient community regarding the US

MTAP, the Myozyme® (alglucosidase alfa) Temporary Access Program, is a clinical program to provide access to Myozyme produced by a

As many of you are aware, a standard part of the biologics drug development process is to incrementally scale-up manufacturing

2006 AMDA/IPA Conference Report By Allan Muir With contributions from George Fox and Jared Salbato Friday—November 17, 2006 Texas Hoe